A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity

Post Stroke Upper Limb Spasticity Clinical Trial

Official title:
A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity

Status Enrolling by invitation

Clinical Trial Summary

- Investigational Product: LIZTOX inj 100unit(HU-014)

- Title : A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity

- Sites and investigators : Asan Medical Center(Seoul), Min-ho Chun, M.D, Ph.D

- Objective : To evaluate the safety of LIZTOX inj in the treatment of Post Stroke Upper Limb Spasticity

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Muscle Spasticity
Post Stroke Upper Limb Spasticity
Stroke

Clinical Trial Details

NCT number	NCT04415346
Study type	Interventional
Source	Huons Co., Ltd.
Contact
Status	Enrolling by invitation
Phase	Phase 1
Start date	November 6, 2019
Completion date	October 2020

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05289921` - To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb	Phase 3